Live Breaking News & Updates on Karolinska development

Stay informed with the latest breaking news from Karolinska development on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Karolinska development and stay connected to the pulse of your community

Karolinska Development's portfolio company PharmNovo´s drug candidate PN6047 in a NIDA funded collaboration

Karolinska Development's portfolio company PharmNovo´s drug candidate PN6047 in a NIDA funded collaboration
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Michigan , United-states , Stockholm , Sweden , Emily-jutkiewicz , Viktor-drvota , Karolinska-institutet , Johan-dighed , Us-national-institute-of-drug-abuse , Professor-amynah-pradhan-at-washington-university , University-of-michigan , Karolinska-development-ab-nasdaq-stockholm

Karolinska Development's portfolio company Umecrine Cognition presents positive effects of golexanolone in a preclinical model of cholestasis

Karolinska Development's portfolio company Umecrine Cognition presents positive effects of golexanolone in a preclinical model of cholestasis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stockholm , Sweden , Viktor-drvota , Karolinska-institutet , Johan-dighed , Karolinska-development , Liver-international , Karolinska-development-ab-nasdaq-stockholm , Nasdaq-stockholm , Umecrine-cognition , General-counsel ,

Interim Report - January-September 2023

STOCKHOLM – 17 November 2023. Karolinska Development AB today publishes its Interim Report - January-September 2023. The full report is available on the Company's website. “It’s clear that our...

Barcelona , Comunidad-autonoma-de-cataluna , Spain , Stockholm , Sweden , Karolinska-institutet , Viktor-drvota , World-parkinson-congress , Karolinska-development , Karolinska-development-ab-nasdaq-stockholm , Nasdaq-stockholm , Interim-report

Karolinska Development's portfolio company Modus Therapeutics raises capital to expand the development program for sevuparin

STOCKHOLM, SWEDEN November 8, 2023. Karolinska Development AB today announces that its portfolio company Modus Therapeutics has decided to carry out a rights issue that can raise up to approximately...

Sweden , Stockholm , Karolinska-institutet , Viktor-drvota , Johan-dighed , Karolinska-development-ab-nasdaq-stockholm , Karolinska-development , Nasdaq-stockholm , Modus-therapeutics , Nasdaq-first-north-growth-market , Modus-therapeutic , Volume-weighted-average-price

Karolinska Development's portfolio company Modus

STOCKHOLM, SWEDEN November 8, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Modus Therapeutics has...

Sweden , Stockholm , Karolinska-institutet , Johan-dighed , Viktor-drvota , Karolinska-development , Karolinska-development-ab-nasdaq-stockholm , Nasdaq-stockholm , Modus-therapeutics , Nasdaq-first-north-growth-market , Modus-therapeutic , Volume-weighted-average-price

Karolinska Development's portfolio company PharmNovo reports positive results from a clinical phase 1 study of drug candidate PN6047

STOCKHOLM, SWEDEN, October 2, 2023. Karolinska Development AB announces that its portfolio company PharmNovo has successfully completed its clinical phase 1 study with PN6047, a drug candidate...

Sweden , Stockholm , Karolinska-institutet , Johan-dighed , Viktor-drvota , Karolinska-development , Karolinska-development-ab-nasdaq-stockholm , Nasdaq-stockholm , General-counsel , Markets ,

Karolinska Development's portfolio company PharmNovo reports promising preclinical results on abuse potential and withdrawal symptom relief for its candidate drug PN6047

STOCKHOLM, SWEDEN, September 28, 2023. Karolinska Development AB announces that its portfolio company PharmNovo has reported promising results in a preclinical study of the company’s drug candidate...

Michigan , United-states , Stockholm , Sweden , Karolinska-institutet , Viktor-drvota , Johan-dighed , Us-national-institute-of-drug-abuse , Washington-university , University-of-michigan , Astrazeneca , Karolinska-development

Karolinska Development's portfolio company OssDsign raises SEK 150 million and makes strategic move to become a pure play orthobiologics company

STOCKHOLM, SWEDEN, September 27, 2023. Karolinska Development AB announces that its portfolio company OssDsign successfully has completed a directed share issue to a value of approximately SEK 150...

Stockholm , Sweden , Johan-dighed , Viktor-drvota , Karolinska-institutet , Karolinska-development , Karolinska-development-ab-nasdaq-stockholm , Investment-fund , Nasdaq-stockholm , Ossdsign-catalyst , General-counsel , Markets

OssDsign has carried out a directed share issue of approximately SEK 150 million

OssDsign has carried out a directed share issue of approximately SEK 150 million
realtid.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from realtid.se Daily Mail and Mail on Sunday newspapers.

South-africa , Singapore , United-states , Canada , Hong-kong , United-kingdom , Sweden , Stockholm , Australia , Japan , Swedish , Anders-svensson

Karolinska Development's portfolio company OssDsign has received FDA clearance for a new major indication

STOCKHOLM, SWEDEN, September 19, 2023. Karolinska Development AB announces that its portfolio company OssDsign has received clearance from FDA for the use of OssDsign Catalyst in interbody cages in...

Sweden , Stockholm , Karolinska-institutet , Johan-dighed , Viktor-drvota , Drug-administration , Karolinska-development-ab-nasdaq-stockholm , Karolinska-development , Investment-fund , Nasdaq-stockholm , Ossdsign-catalyst , Dsign-catalyst